Primary Sjögren syndrome manifested as localized cutaneous nodular amyloidosis

Journal of Clinical Rheumatology

Volumn 17, Issue 7, 2011, Pages 368-370

  Wey, Shiow Jiuan ^a   Chen, Yi Ming ^b,c   Lai, Po Ju ^a   Chen, Der Yuan ^b,c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

immunoglobulin; light chain; localized cutaneous nodular amyloidosis; Sj gren syndrome

Indexed keywords

ALBUMIN; AMYLOID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CENTROMERE ANTIBODY; CREATININE; GLOBULIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PREDNISONE;

AGED; ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; CASE REPORT; CELL INFILTRATION; CREATININE BLOOD LEVEL; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN DEFICIENCY; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIGHT CHAIN; LOCALIZED CUTANEOUS NODULAR AMYLOIDOSIS; PLASMA CELL; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN EXAMINATION;

AGED; AMYLOIDOSIS; ANTIRHEUMATIC AGENTS; AZATHIOPRINE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; IMMUNOHISTOCHEMISTRY; PREDNISONE; SJOGREN'S SYNDROME; SKIN DISEASES;

EID: 80053381891     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31823209ba     Document Type: Article

References (11)

1. Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis review and long-term follow-up of 16 cases. Arch Dermatol. 2003;139:1157-1159.
2. Schwendiman MN, Beachkofsky TM, Wisco OJ, et al. Primary cutaneous nodular amyloidosis: Case report and review of the literature. Cutis. 2009;84:87-92.
3. Meijer JM, Schonland SO, Palladini G, et al. Sjogren's syndrome and localized nodular cutaneous amyloidosis: Coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58:1992-1999.
4. Schall GL, Anderson LG, Wolf RO, et al. Xerostomia in Sjogren's syndrome: Evaluation by sequential salivary scintigraphy. JAMA. 1971;28:2109-2116.
5. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
6. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis [review]. N Engl J Med. 2003;349:583-596.
7. Ito K, Hashimoto K, Kambe N, et al. Role of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis. J Invest Dermatol. 1987 89 415-419.
8. Masuda C, Mohri S, Nakajima H. Histopathological and immunohistochemical study of amyloidosis cutis nodularis atrophicansVcomparison with systemic amyloidosis. Br J Dermatol. 1988;119:33-43.
9. Rubinow A, Cohen AS. Skin involvement in generalized amyloidosis: A study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis. Ann Intern Med. 1978;88:781-785.
10. Hansen A, Lipsky PE, Dorner T. Immunopathogenesis of primary Sjogren's syndrome: Implications for disease management and therapy [review]. Curr Opin Rheumatol. 2005;17:558-565.
11. Yoneyama K, Tochigi N, Oikawa A, et al. Primary localized cutaneous nodular amyloidosis in a patient with Sjogren's syndrome: A review of the literature [review]. J Dermatol. 2005;32:120-123.